Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 60,000 shares at $61.41 ($3.6M) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Scheduled sale ($3.6M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.41 | 7,946 | $488K | 13.4% |
| 2 | $61.41 | 7,946 | $488K | 13.4% |
| 3 | $60.76 | 10,607 | $644K | 17.7% |
| 4 | $60.76 | 10,607 | $644K | 17.7% |
| 5 | $59.86 | 11,447 | $685K | 18.8% |
| 6 | $59.86 | 11,447 |
| $685K |
| 18.8% |
| Total | $60.59 avg | 60,000 | $3.6M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |